← Back to Search

Behavioural Intervention

Most hoped for future self, 3 dose for Alcohol Use Disorder

N/A
Recruiting
Led By Kristen Lindgren, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up will be assessed at baseline, 1-month follow up, 3-month follow up, 6 month-follow up, & 12-month follow up
Awards & highlights

Study Summary

This trial aims to see if a task called Future Possible Self Task (FPST) can change how much someone associates themselves with drinking and if this change can reduce the risks of alcohol misuse in individuals graduating

Who is the study for?
This trial is for high school seniors aged 17-19 in Seattle or Houston who have drunk alcohol at least once last year. They should be interested in not increasing their drinking or reducing it, fluent in English, and willing to attend three virtual sessions on Zoom.Check my eligibility
What is being tested?
The study tests a writing task called the future possible self task (FPST) to see if it can change how much participants identify with drinking and reduce risks of alcohol misuse. It compares different versions of FPST and frequency (one vs. three sessions).See study design
What are the potential side effects?
There are no direct physical side effects expected from participating in this trial as it involves writing tasks and questionnaires. However, discussing personal attitudes towards alcohol may cause discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be assessed at baseline, 1-month follow up, 3-month follow up, 6 month-follow up, & 12-month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and will be assessed at baseline, 1-month follow up, 3-month follow up, 6 month-follow up, & 12-month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol-related problems
Drinks per week
Explicit drinking identity
+3 more
Secondary outcome measures
Alcohol Craving - Momentary
Alcohol Craving - Retrospective
Alcohol Expectancies
+6 more

Trial Design

8Treatment groups
Experimental Treatment
Placebo Group
Group I: Most hoped future self, 1 doseExperimental Treatment1 Intervention
Participants complete a writing task in which they think and write about their most hoped for future self one time (on the third session).
Group II: Most hoped for future self, 3 doseExperimental Treatment1 Intervention
Participants complete a writing task in which they think and write about their most hoped for future self, weekly for 3 weeks (i.e., at each session).
Group III: Most feared future self, 3 doseExperimental Treatment1 Intervention
Participants complete a writing task in which they think and write about their most feared future self, weekly for 3 weeks (i.e., at each session).
Group IV: Most feared future self, 1 doseExperimental Treatment1 Intervention
Participants complete a writing task in which they think and write about their most feared future self one time (on the third session).
Group V: Balanced self (hoped and feared self), 3 doseExperimental Treatment1 Intervention
Participants complete a writing task in which they think and write about their most hoped for and feared future self, weekly for 3 weeks (i.e., at each session).
Group VI: Balanced self (hoped and feared self), 1 doseExperimental Treatment1 Intervention
Participants complete a writing task in which they think and write about their most hoped for and feared future self one time (on the third session).
Group VII: Control, 1 dosePlacebo Group1 Intervention
Participants in this condition complete a task in which they think and write about a trip to the zoo one time (on the third session).
Group VIII: Control, 3 dosePlacebo Group1 Intervention
Participants in this condition complete a task in which they think and write about a trip to the zoo weekly for 3 weeks (i.e., at each session).

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,238 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
802 Previous Clinical Trials
1,364,917 Total Patients Enrolled
Kristen Lindgren, PhDPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
500 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants younger than 50 years old eligible for enrollment in this study?

"Volunteers aged 17 years and older but younger than 19 are eligible for enrollment in this investigation."

Answered by AI

What is the current number of individuals involved in this clinical trial as participants?

"Indeed, data available on clinicaltrials.gov reveals that this investigation is actively seeking eligible individuals. The trial was initially listed on March 4th, 2024 and underwent its latest update on March 6th, 2024. A total of 528 participants are sought at a singular research site."

Answered by AI

Who is eligible to participate in this clinical trial?

"For this research study, 528 individuals aged between 17 and 19 years with alcohol use disorder are being recruited. Essential qualifications include expressing some level of interest in either not escalating drinking habits or diminishing consumption, being a high school senior anticipated to graduate by the end of the academic year, residing within greater Seattle (UW Site) or Houston (UH Site), possessing fluency in English, committing to participate in three virtual laboratory sessions weekly via Zoom, agreeing to disclose contact details such as phone number for text messages and reminders, email for notifications, and mailing address for payments. Additionally important is having consumed alcohol at least once during the"

Answered by AI

Are patients currently able to enroll in this ongoing study?

"Indeed, data on clinicaltrials.gov confirms the ongoing patient recruitment for this study. The trial was initially listed on March 4th, 2024, and last modified on March 6th, 2024. A total of 528 patients are sought from a singular research site."

Answered by AI
~352 spots leftby Oct 2026